L
Lily McLaughlin
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 23
Citations - 759
Lily McLaughlin is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 14, co-authored 21 publications receiving 561 citations.
Papers
More filters
Journal ArticleDOI
The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yoshiya Yamada,Evangelia Katsoulakis,Ilya Laufer,Michael Lovelock,Ori Barzilai,Lily McLaughlin,Zhigang Zhang,Adam M. Schmitt,Daniel S. Higginson,Eric Lis,Michael J. Zelefsky,James Mechalakos,Mark H. Bilsky +12 more
TL;DR: High-dose single-session SRS provides durable long-term control, regardless of the histological findings or tumor size, suggesting that radioresistant histological types benefit in particular from radiosurgery.
Journal ArticleDOI
Short-segment percutaneous pedicle screw fixation with cement augmentation for tumor-induced spinal instability
Nelson Moussazadeh,David G. Rubin,Lily McLaughlin,Eric Lis,Mark H. Bilsky,Mark H. Bilsky,Ilya Laufer,Ilya Laufer +7 more
TL;DR: Percutaneous cement-augmented percutaneous posterolateral spinal fixation is a safe and effective option for palliation of appropriately selected mechanically unstable VCF that extends into pedicle and/or joint.
Journal ArticleDOI
Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
Nelson Moussazadeh,Nelson Moussazadeh,Eric Lis,Evangelia Katsoulakis,Sweena Kahn,Marek Svoboda,Natalie DiStefano,Lily McLaughlin,Mark H. Bilsky,Mark H. Bilsky,Yoshiya Yamada,Ilya Laufer,Ilya Laufer +12 more
TL;DR: In the longest-term series to date, high-dose single-fraction spinal SRS retained an excellent safety profile among long-term survivors (>5 years), and was associated with acute grade 1 cutaneous or gastrointestinal toxicity.
Journal ArticleDOI
The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.
Nuno Rui Paulino Pereira,Lily McLaughlin,Stein J. Janssen,Cornelis Niek van Dijk,Jos A. M. Bramer,Ilya Laufer,Mark H. Bilsky,Joseph H. Schwab +7 more
TL;DR: SORG12 nomogram and SORG classic algorithm at estimating survival in patients with spine metastatic disease are validated and predictive accuracy with other survival algorithms are compared.
Journal ArticleDOI
Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery.
Ibrahim Hussain,Ori Barzilai,Anne S. Reiner,Natalie DiStefano,Lily McLaughlin,Shahiba Ogilvie,Mark H. Bilsky,Ilya Laufer,Ilya Laufer +8 more
TL;DR: In this article, a single-institution prospective cohort study was carried out to determine if SINS correlates with patient-reported preoperative pain and disability, and if surgical stabilization significantly improves patientreported outcomes (PROs).